456 related articles for article (PubMed ID: 25975725)
1. Value of neutrophil-lymphocyte ratio in predicting outcomes in Kawasaki disease.
Ha KS; Lee J; Jang GY; Lee J; Lee KC; Son CS; Lee JW
Am J Cardiol; 2015 Jul; 116(2):301-6. PubMed ID: 25975725
[TBL] [Abstract][Full Text] [Related]
2. High neutrophil : lymphocyte ratio is associated with refractory Kawasaki disease.
Cho HJ; Bak SY; Kim SY; Yoo R; Baek HS; Yang S; Hwang IT; Ban JE
Pediatr Int; 2017 Jun; 59(6):669-674. PubMed ID: 28097746
[TBL] [Abstract][Full Text] [Related]
3. [Values of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in predicting sensitivity to intravenous immunoglobulin in Kawasaki disease].
Yuan YD; Sun J; Li PF; Wei CL; Yu YH
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Apr; 19(4):410-413. PubMed ID: 28407827
[TBL] [Abstract][Full Text] [Related]
4. The Combined Usefulness of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Predicting Intravenous Immunoglobulin Resistance with Kawasaki Disease.
Kawamura Y; Takeshita S; Kanai T; Yoshida Y; Nonoyama S
J Pediatr; 2016 Nov; 178():281-284.e1. PubMed ID: 27526622
[TBL] [Abstract][Full Text] [Related]
5. The combination of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as a novel predictor of intravenous immunoglobulin resistance in patients with Kawasaki disease: a multicenter study.
Kanai T; Takeshita S; Kawamura Y; Kinoshita K; Nakatani K; Iwashima S; Takizawa Y; Hirono K; Mori K; Yoshida Y; Nonoyama S
Heart Vessels; 2020 Oct; 35(10):1463-1472. PubMed ID: 32449049
[TBL] [Abstract][Full Text] [Related]
6. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
Chantasiriwan N; Silvilairat S; Makonkawkeyoon K; Pongprot Y; Sittiwangkul R
Paediatr Int Child Health; 2018 Aug; 38(3):209-212. PubMed ID: 29768976
[TBL] [Abstract][Full Text] [Related]
7. Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease- a data from multi-institutional study in China.
Li G; Wang T; Gou Y; Zeng R; Liu D; Duan Y; Liu B
Int Immunopharmacol; 2020 Dec; 89(Pt A):107037. PubMed ID: 33242833
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (ivig)-resistance in Kawasaki disease.
Takeshita S; Kanai T; Kawamura Y; Yoshida Y; Nonoyama S
PLoS One; 2017; 12(5):e0176957. PubMed ID: 28542183
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
Sato S; Kawashima H; Kashiwagi Y; Hoshika A
Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of laboratory predictors for intravenous immunoglobulin resistance and coronary artery aneurysm in Kawasaki Disease before and after therapy.
Liu J; Ye B; Su D; Qin S; Zhao W; Pang Y
Clin Rheumatol; 2023 Jan; 42(1):167-177. PubMed ID: 36129563
[TBL] [Abstract][Full Text] [Related]
11. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
[TBL] [Abstract][Full Text] [Related]
12. Predicting IVIG resistance in UK Kawasaki disease.
Davies S; Sutton N; Blackstock S; Gormley S; Hoggart CJ; Levin M; Herberg JA
Arch Dis Child; 2015 Apr; 100(4):366-8. PubMed ID: 25670405
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pretreatment prognostic nutritional index in intravenous immunoglobulin-resistant Kawasaki disease.
Li G; Xu X; Chen P; Zeng R; Liu B
Heart Vessels; 2021 Sep; 36(9):1366-1373. PubMed ID: 33686555
[TBL] [Abstract][Full Text] [Related]
14. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children.
Wu S; Liao Y; Sun Y; Zhang CY; Zhang QY; Yan H; Qi JG; Liu XQ; Chen YH; Wang YL; Li XY; Jin HF; Du JB
World J Pediatr; 2020 Dec; 16(6):607-613. PubMed ID: 32232677
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-to-lymphocyte ratio and scoring system for predicting coronary artery lesions of Kawasaki disease.
Chang LS; Lin YJ; Yan JH; Guo MM; Lo MH; Kuo HC
BMC Pediatr; 2020 Aug; 20(1):398. PubMed ID: 32838756
[TBL] [Abstract][Full Text] [Related]
16. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
[TBL] [Abstract][Full Text] [Related]
18. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
Li W; He X; Zhang L; Wang Z; Wang Y; Lin H; Yuan J; Xie X; Qin Y; Huang P
Cardiovasc Ther; 2021; 2021():6660407. PubMed ID: 34239607
[TBL] [Abstract][Full Text] [Related]
19. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
Kuo HC; Liang CD; Wang CL; Yu HR; Hwang KP; Yang KD
Acta Paediatr; 2010 Oct; 99(10):1578-83. PubMed ID: 20491705
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
Wu Y; Liu FF; Xu Y; Wang JJ; Samadli S; Wu YF; Liu HH; Chen WX; Luo HH; Zhang DD; Wei W; Hu P
Clin Exp Med; 2019 May; 19(2):173-181. PubMed ID: 30617865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]